US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Abivax SA

103.95

+2.232.19%

Volume:350.00

Turnover:36.38K

Market Cap:7.81B

PE:-27.41

High:103.95

Open:103.95

Low:103.95

Close:101.72

52wk High:105.75

52wk Low:5.81

Shares:75.15M

Float Shares:40.35M

Volume Ratio:0.07

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.7919

EPS(LYR):-3.7919

ROE:-499.78%

ROA:-57.74%

PB:-140.37

PE(LYR):-27.41

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Abivax SA

Exchange:

PINK LIMITED

Establishment Date:

2013

Employees:

69

Office Location:

7-11 boulevard Haussmann,Paris,Ile-de-France,France

Website:

http://www.abivax.com/en/

Zip Code:

75009

Phone:

33 1 53 83 09 63

Fax:

- -

Introduction:

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AAVXF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AAVXF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAVXF\",,,,,undefined,":{"symbol":"AAVXF","market":"US","secType":"STK","nameCN":"Abivax SA","latestPrice":103.95,"timestamp":1761928884459,"preClose":101.72,"halted":0,"volume":350,"delay":15,"floatShares":40348713,"shares":75151333,"eps":-3.791917,"marketStatus":"Post-Mkt","change":2.23,"latestTime":"10-31 12:41:24 EDT Delay","open":103.95,"high":103.95,"low":103.95,"amount":36382.5,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-3.791917,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1761955200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":101.72,"volumeRatio":0.068179},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAVXF\",,,,,undefined,":{"symbol":"AAVXF","floatShares":40348713,"roa":"-57.74%","roe":"-499.78%","lyrEps":-3.791917,"volumeRatio":0.068179,"shares":75151333,"dividePrice":0,"high":103.95,"amplitude":0,"preClose":101.72,"low":103.95,"week52Low":5.81,"pbRate":"-140.37","psRate":"1125.18","week52High":105.75,"institutionHeld":0,"latestPrice":103.95,"eps":-3.791917,"divideRate":0,"volume":350,"delay":15,"ttmEps":-3.791917,"open":103.95,"prevYearClose":7.37,"prevWeekClose":88.55,"prevMonthClose":86.1,"prevQuarterClose":86.1,"fiveDayClose":88.55,"twentyDayClose":86.1,"sixtyDayClose":71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AAVXF\",params:#limit:5,,,undefined,":[{"date":"2022-09-30","symbol":"AAVXF","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1664568000000,"name":null,"time":"Post Market","dateTimestamp":1664510400000,"actualEps":null},{"date":"2022-04-15","symbol":"AAVXF","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1650052800000,"name":null,"time":"Post Market","dateTimestamp":1649995200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AAVXF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AAVXF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.375,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1761278400000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":256839883,"yearFounded":2013,"employeeNum":69,"address":"7-11 boulevard Haussmann,Paris,Ile-de-France,France","zipCode":"75009","officePhone":"33 1 53 83 09 63"},"stockCompanyDetail":{"websiteUrl":"http://www.abivax.com/en/","stockEarnings":[{"period":"1week","weight":-0.0558},{"period":"1month","weight":-0.0591},{"period":"3month","weight":-0.0922},{"period":"6month","weight":-0.2425},{"period":"1year","weight":0.1357},{"period":"ytd","weight":-0.2711}],"description":"ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.","exchange":"PINK LIMITED","name":"Abivax SA","nameEN":"Abivax SA"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AAVXF\",market:\"US\",,,undefined,":null}}